Deferasirox

FDA Approved: * January 26, 2016
Pharm Company: * ACTAVIS ELIZABETH
Category: Iron Chelator

Deferasirox, sold under the brand name Exjade & Asunra (in injectable form) & Oleptiss (Tablet formulation) both by Novartis among others, is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.[2][3] It is the first oral medication approved in the United States for this purpose.[4] It was appro... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.